Kurt A. Gustafson

2013 - Halozyme Therapeutics

In 2013, Kurt A. Gustafson earned a total compensation of $691K as Former Vice President and Chief Financial Officer at Halozyme Therapeutics, a 63% decrease compared to previous year.

Compensation breakdown

Option Awards$247,733
Salary$193,290
Stock Awards$243,660
Other$6,271
Total$690,954

Gustafson received $247.7K in option awards, accounting for 36% of the total pay in 2013.

Gustafson also received $193.3K in salary, $243.7K in stock awards and $6.3K in other compensation.

Rankings

In 2013, Kurt A. Gustafson's compensation ranked 8,187th out of 12,286 executives tracked by ExecPay. In other words, Gustafson earned more than 33.4% of executives.

ClassificationRankingPercentile
All
8,187
out of 12,286
33rd
Division
Manufacturing
2,963
out of 4,612
36th
Major group
Chemicals And Allied Products
922
out of 1,462
37th
Industry group
Drugs
699
out of 1,156
40th
Industry
Biological Products, Except Diagnostic Substances
114
out of 196
42nd
Source: SEC filing on April 7, 2014.

Gustafson's colleagues

We found five more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2013.

2013

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

2013

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2013

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

2013

Jean Liu

Halozyme Therapeutics

General Counsel

2013

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

News

You may also like